Hunan Fangsheng Pharmaceutical Co., Ltd. (SHSE: 603998)
Health Care · Pharmaceuticals · CN
CN¥9.93
-7.88% today · -21.4% 1Y
Hunan Fangsheng Pharmaceutical Co., Ltd. (SHSE: 603998) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $648.59M and employs 1,868 people.
Over the last twelve months the share price has lost 21.4%, trading between 8.64 and 13.50.
Tweenvest scores Hunan Fangsheng Pharmaceutical Co., Ltd. across four factors: quality 72/100, value 70/100, growth 77/100, dividend 81/100. Its strongest factor is dividend.
603998 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $648.59M
- Revenue (TTM)
- $259.68M
- P/E
- 14.18
- EPS
- 0.70
- Dividend yield
- 4.53%
- Beta (5Y)
- 0.26
- 52-week high
- CN¥13.50
- 52-week low
- CN¥8.64
- Avg volume (3M)
- —
- Shares outstanding
- 439.08M
- Employees
- 1,868
- Next earnings
- —
About Hunan Fangsheng Pharmaceutical Co., Ltd.
Operating within China, Hunan Fangsheng Pharmaceutical Co., Ltd. is engaged in the complete spectrum of pharmaceutical activities, from research and development to manufacturing and sales. Its diverse product line encompasses tablets, capsules, and granules, addressing a wide array of therapeutic areas such as cardiovascular, cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infective conditions. The company was established in 2002 and is headquartered in Changsha, China.
- ISIN
- CNE100001VG6
- Founded
- 2000
- Listed since
- Dec 5, 2014
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,240.63 | -1.18% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.52 | +0.47% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.55 | -1.31% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.93 | -0.50% |
Figures last refreshed Aug 18, 2026.